Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd. > Market still wide open for Bucillamine !
View:
Post by cool888 on Aug 25, 2022 8:41am

Market still wide open for Bucillamine !

#Bucillamine https://twitter.com/TheDalesReport/status/1562555254125711360
Comment by 90guppy on Aug 25, 2022 9:19am
Look Cool, maybe you should start calling out MFrank, maybe that will work to convince them to have urgency for once, peak covid just passed and we are just waiting for crumbs.
Comment by cool888 on Aug 25, 2022 9:07pm
Am sure you could do that yourself - GL !
Comment by 90guppy on Aug 26, 2022 9:12am
And you think I dont, all you do is pom-pom, are you getting paid to do pom-pom?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities